Study of possible correlation between EXCORIATION and ACAI

Accompanying discussion about FactMed users Questions and Concerns

 

About this FactMed analysis covering adverse side effect reports of ACAI patients who developed EXCORIATION.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 3 individuals taking ACAI reported EXCORIATION to the FDA. A total of 25 ACAI drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ACAI and EXCORIATION. In doing so, we compare ACAI with other drugs that cause EXCORIATION, to help you evaluate whether or not ACAI causes EXCORIATION. Likewise, this page shows the most highly-reported side effects of ACAI, so you can see if EXCORIATION ranks among ACAI's most well-known side effects.
Summary Statistics
Reports of ACAI causing EXCORIATION: 3
Reports of any side effect of ACAI : 25
Percentage of ACAI patients where EXCORIATION is a reported side effect: 12.0000%

FDA reports of any drug causing EXCORIATION : 2985
Average percentage for all medicated patients where EXCORIATION is reported as a complication: 0.0187%

Physician opinion on ACAI as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ACAI:
VITAMIN SUPPLEMENTATION ( 6 patients )
DRUG USE FOR UNKNOWN INDICATION ( 3 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2 patients )
MEDICAL DIET ( 1 patients )
ROUTINE HEALTH MAINTENANCE ( 1 patients )
SUPPLEMENTATION THERAPY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with EXCORIATION:

FOSAMAX (1011 patients)
VIOXX (361 patients)
ASPIRIN (350 patients)
MAGNEVIST (247 patients)
ZOMETA (191 patients)
LIPITOR (186 patients)
NEURONTIN (182 patients)
LASIX (179 patients)
AMBIEN (167 patients)
HUMIRA (164 patients)
AVONEX (161 patients)
ALENDRONATE SODIUM (160 patients)
PREDNISONE (158 patients)
NEXIUM (155 patients)
FOLIC ACID (153 patients)
ENBREL (152 patients)
TYSABRI (152 patients)
XANAX (144 patients)
OXYCODONE HCL (144 patients)
SYNTHROID (143 patients)
SEROQUEL (143 patients)
NORVASC (142 patients)
COUMADIN (142 patients)
VITAMIN D (141 patients)
OXYCONTIN (140 patients)
LISINOPRIL (135 patients)
FORTEO (135 patients)
PROTONIX (135 patients)
ZOLOFT (132 patients)
PRILOSEC (130 patients)
HYDROCHLOROTHIAZIDE (127 patients)
VICODIN (118 patients)
LANTUS (117 patients)
POTASSIUM CHLORIDE (117 patients)
METHOTREXATE (115 patients)
CALCIUM (UNSPECIFIED) (106 patients)
ACETAMINOPHEN (105 patients)
OMEPRAZOLE (105 patients)
DIGOXIN (105 patients)
PERCOCET (102 patients)
IBUPROFEN (102 patients)
ATIVAN (101 patients)
CELEBREX (100 patients)
FUROSEMIDE (100 patients)
ALBUTEROL (99 patients)
DIOVAN (96 patients)
PREMARIN (95 patients)
PROZAC (94 patients)
WELLBUTRIN (93 patients)
PLAVIX (92 patients)
ATENOLOL (89 patients)
TOPROL-XL (89 patients)
SIMVASTATIN (89 patients)
BACLOFEN (85 patients)
CELEXA (85 patients)
ZOCOR (85 patients)
LEXAPRO (81 patients)
LORTAB (80 patients)
ALPRAZOLAM (79 patients)
ZANTAC (78 patients)
DILAUDID (77 patients)
CEPHALEXIN (77 patients)
CLONAZEPAM (77 patients)
GABAPENTIN (76 patients)
ZOFRAN (75 patients)
ALLOPURINOL (75 patients)
NITROGLYCERIN (73 patients)
DIAZEPAM (73 patients)
LEVAQUIN (72 patients)
METOCLOPRAMIDE (71 patients)
AUGMENTIN '125' (71 patients)
TRAZODONE HCL (71 patients)
LOVENOX (70 patients)
EFFEXOR (69 patients)
LEVOTHYROXINE SODIUM (69 patients)
ACTONEL (68 patients)
PAXIL (68 patients)
REGLAN (67 patients)
BONIVA (65 patients)
TRAMADOL HCL (65 patients)
LORAZEPAM (65 patients)
MULTI-VITAMIN (64 patients)
ACCUTANE (63 patients)
OMNISCAN (63 patients)
LOPRESSOR (63 patients)
AMOXICILLIN (62 patients)
CYMBALTA (61 patients)
COREG (61 patients)
LYRICA (60 patients)
PREVACID (60 patients)
FENTANYL (60 patients)
AREDIA (60 patients)
DEXAMETHASONE (60 patients)
PROMETHAZINE (60 patients)
NYSTATIN (59 patients)
MULTI-VITAMINS (59 patients)
METFORMIN HCL (59 patients)
GLUCOPHAGE (58 patients)
FOSAMAX PLUS D (58 patients)
CITALOPRAM HYDROBROMIDE (56 patients)
ASCORBIC ACID (56 patients)
ZYRTEC (55 patients)
CHEMOTHERAPEUTICS NOS (55 patients)
VANCOMYCIN (54 patients)
VITAMIN B-12 (54 patients)
ALLEGRA (54 patients)
PREDNISONE TAB (54 patients)
CLARITIN (53 patients)
MORPHINE (53 patients)
BENADRYL (53 patients)
CIPROFLOXACIN (52 patients)
CALCIUM (52 patients)
ZYPREXA (52 patients)
CRESTOR (52 patients)
THALIDOMIDE (52 patients)
GLIPIZIDE (52 patients)
NIASPAN (51 patients)
FISH OIL (51 patients)
KEFLEX (50 patients)
VALIUM (50 patients)
ULTRAM (50 patients)
METOPROLOL TARTRATE (50 patients)
WARFARIN SODIUM (49 patients)
INSULIN (49 patients)
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (48 patients)
FERROUS SULFATE TAB (48 patients)
CALCIUM CARBONATE (48 patients)
CLONIDINE (47 patients)
DEPAKOTE (47 patients)
KEPPRA (47 patients)
IRON (47 patients)
RENAGEL (47 patients)
SINGULAIR (46 patients)
HUMALOG (46 patients)
ACTOS (45 patients)
DOCUSATE SODIUM (45 patients)
ARANESP (45 patients)
KLONOPIN (45 patients)
CHANTIX (45 patients)
OXYCODONE (45 patients)
COZAAR (44 patients)
ADVAIR DISKUS 100/50 (44 patients)
SUTENT (44 patients)
BETASERON (44 patients)
ELAVIL (44 patients)
MORPHINE SULFATE (44 patients)
BYETTA (44 patients)
TYLENOL (CAPLET) (44 patients)
VITAMINS (UNSPECIFIED) (44 patients)
[THERAPY UNSPECIFIED] (43 patients)
TEMAZEPAM (43 patients)
HYDROCODONE (43 patients)
LIDODERM (42 patients)
TRICOR (42 patients)
FLUOXETINE (42 patients)
AMLODIPINE (42 patients)
OPTIMARK (41 patients)
SOMA (41 patients)
FLEXERIL (41 patients)
VITAMIN E (41 patients)
DARVOCET (41 patients)
SPIRONOLACTONE (41 patients)
MIRAPEX (40 patients)
AMITRIPTYLINE HCL (40 patients)
LACTULOSE (39 patients)
FLUCONAZOLE (39 patients)
LITHIUM CARBONATE (39 patients)
PRAVACHOL (39 patients)
MONOPRIL (39 patients)
GLUCOVANCE (38 patients)
MECLIZINE (38 patients)
ALTACE (38 patients)
REMICADE (38 patients)
CHLORHEXIDINE GLUCONATE (37 patients)
GLYBURIDE (37 patients)
MOTRIN (37 patients)
NAPROXEN (37 patients)
RANITIDINE (37 patients)
BACTRIM (37 patients)
EPOGEN (37 patients)
BUSPAR (37 patients)
CLINDAMYCIN (37 patients)
DETROL (37 patients)
MIRALAX (37 patients)
PEG-INTERFERON ALFA 2A (RO 25-8310) (37 patients)
PENICILLIN VK (36 patients)
ACCUPRIL (36 patients)
LOTREL (36 patients)
ATROVENT (36 patients)
ZITHROMAX (35 patients)
METOPROLOL (35 patients)
FLONASE (35 patients)
TYLENOL (35 patients)
RADIATION THERAPY (35 patients)
HYDROCODONE BITARTRATE (35 patients)
DECADRON (35 patients)
HYDROMORPHONE HCL (34 patients)
PEPCID (34 patients)
RESTORIL (34 patients)
ZOSYN (34 patients)
HYDROCORTISONE (34 patients)
FLOMAX (34 patients)
VITAMIN D (UNSPECIFIED) (33 patients)
METFORMIN (33 patients)
AMARYL (33 patients)
PANTOPRAZOLE (33 patients)
RISPERDAL (32 patients)
LAMICTAL (32 patients)
AVANDIA (32 patients)
COLACE (32 patients)
Most common side effects for patients taking ACAI:
RENAL FAILURE ACUTE (6 patients)
ATRIOVENTRICULAR BLOCK SECOND DEGREE (5 patients)
FALL (5 patients)
NEUROPATHY PERIPHERAL (4 patients)
MEMORY IMPAIRMENT (3 patients)
WEIGHT DECREASED (3 patients)
MUSCLE TWITCHING (3 patients)
FATIGUE (3 patients)
VISUAL ACUITY REDUCED (3 patients)
BALANCE DISORDER (3 patients)
STRESS (3 patients)
EXCORIATION (3 patients)
ERYTHEMA (3 patients)
COGNITIVE DISORDER (3 patients)
COORDINATION ABNORMAL (3 patients)
PAIN (3 patients)
DEHYDRATION (3 patients)
DERMATITIS INFECTED (2 patients)
PRODUCT ADHESION ISSUE (2 patients)
PAIN IN EXTREMITY (2 patients)
RASH (2 patients)
ONYCHOCLASIS (2 patients)
DRY SKIN (2 patients)
ONYCHALGIA (2 patients)
CARPAL TUNNEL SYNDROME (2 patients)
ROTATOR CUFF REPAIR (2 patients)
ROTATOR CUFF SYNDROME (2 patients)
EXOSTOSIS (2 patients)
TRANSITIONAL CELL CARCINOMA (2 patients)
VISUAL IMPAIRMENT (2 patients)
NAUSEA (2 patients)
GASTROENTERITIS VIRAL (2 patients)
NASOPHARYNGITIS (2 patients)
HOT FLUSH (2 patients)
VOMITING (2 patients)
LIMB CRUSHING INJURY (2 patients)
INCISION SITE HAEMORRHAGE (2 patients)
LOWER EXTREMITY MASS (2 patients)
INSOMNIA (1 patients)
KIDNEY INFECTION (1 patients)
ABDOMINAL PAIN (1 patients)
INFLUENZA LIKE ILLNESS (1 patients)
HYPONATRAEMIA (1 patients)
MONOPLEGIA (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE SCLEROSIS RELAPSE (1 patients)
HYPERTENSION (1 patients)
MYALGIA (1 patients)
HERPES ZOSTER (1 patients)
FEELING HOT (1 patients)
EAR INFECTION (1 patients)
NEUTROPENIA (1 patients)
NON-HODGKIN'S LYMPHOMA (1 patients)
DYSPEPSIA (1 patients)
DRUG INEFFECTIVE (1 patients)
OROPHARYNGEAL PAIN (1 patients)
DIZZINESS (1 patients)
DIVERTICULITIS (1 patients)
PHARYNGITIS (1 patients)
DIARRHOEA (1 patients)
PYREXIA (1 patients)
CYSTITIS (1 patients)
RENAL CYST (1 patients)
BLOOD TRIGLYCERIDES INCREASED (1 patients)
RHEUMATOID ARTHRITIS (1 patients)
BLOOD PRESSURE INCREASED (1 patients)
BLADDER DISORDER (1 patients)
SHOCK (1 patients)
SKIN LACERATION (1 patients)
STAPHYLOCOCCAL INFECTION (1 patients)
BLADDER CANCER (1 patients)
SYSTEMIC LUPUS ERYTHEMATOSUS (1 patients)
BASAL CELL CARCINOMA (1 patients)
URTICARIA (1 patients)
UVEITIS (1 patients)
ASTHENIA (1 patients)
ARTHRALGIA (1 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (1 patients)
ACUTE HEPATIC FAILURE (1 patients)
WOUND INFECTION (1 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ACAI

Issue Description / Topic Timestamp
QUESTION
BURNING SENSATION		I have not taken acai berry but have experienced a burning sensation and a tingling "pins and needles" sensation from taking maqui berry capsules. There is very little research on humans on maqui berry's side effects. I am wondering if anyone else has experienced similar. M 2017-05-09 17:39:37

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about EXCORIATION and ACAI, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ACAI, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ACAI. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ACAI experts. If you are a healthcare provider experienced in prescribing ACAI, please register here.
giCould not connect: